In Vitro Diagnostics Business Outlook, Volume 3, Issue 2 - Focus on Immunoassay Overview
ISSUE 2 OF 6 - In Vitro Diagnostics Business Outlook, Volume 3, Issue 2 - Focus on Immunoassay
(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.
In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:
Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
- A comprehensive view of the IVD market with test categories covered and company briefs
- M&A activities, selected partnerships & collaborations, partnership deals, and more
- Industry & region watch to help tailor strategies
- Analysis of news and events and reporting on news not easily available
- MARKET ANALYSIS
- OVERVIEW OF IVD IMMUNOASSAY
- MARKET OUTLOOK
- Table: Global Lab-Based Immunoassay Market by Segment, 2023-2028 ($ millions)
- Figure: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)
- REGIONAL MARKET
- Table: Global Immunoassay Market (Lab-Based) Sales Distribution, by Region, 2023 (%) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
- Figure: Global Immunoassay Market Sales Distribution, Top 10 Country Markets, 2023 (%)
- TOP COMPANY BRIEFS
- Roche
- Abbott Diagnostics
- Siemens Healthineers
- Other Selected Immunoassay News
- EXECUTIVE NEWS BRIEFING
- NOWDIAGNOSTICS SELECTS NEW SCIENCE OFFICER
- FREENOME RAISES $254 MILLION IN NEW FUNDING
- QUIDELORTHO AXES CEO
- AGILENT CEO TO RETIRE
- FINANCIAL HIGHLIGHTS: BIO-RAD LABORATORIES AND VERACYTE
- BIO-RAD LABORATORIES REPORTS FULL-YEAR 2023 CLINICAL DIAGNOSTICS REVENUES UP 3.2% OVER PREVIOUS YEAR
- Table: Bio-Rad Laboratories Net Sales, 2021-2023 ($M)
- Figure: Bio-Rad Laboratories’ Sales by Business, 2022 vs. 2023, $M
- Figure: Bio-Rad Laboratories Quarterly Performance by Business, 2022 vs. 2023 ($M)
- Figure: Bio-Rad Laboratories 2022 and 2023 Regional Sales Breakdown Distribution
- VERACYTE REPORTED STRONG PERFORMANCE IN 2023
- Figure: Veracyte 12-Month (FY22 and FY23) Sales by Division (Testing, Product, Biopharmaceutical and Other), Thousands USD
- DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
- MERGERS AND ACQUISITIONS
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
- PARTNERSHIPS AND COLLABORATIONS
- INDUSTRY WATCH
- VIRUS TESTING UPDATE
- REGION WATCH
- PERU
- Figure: Peru Population Distribution by Broad Age Group, 2023 and 2040 Estimates
- Figure: Peru GDP Value and Growth by Year, 2010-2022
- Figure: Peru COVID-19 Lab Samples Tested and Positivity by Region, Cumulative 2020-2023
- SOUTH AFRICA
- Figure: South Africa Population Pyramid, 2023 and 2033 Estimates
- Figure: South Africa GDP, Composition by Sector (Agriculture, Industry, Services)
- BROAD-BASED COMPANY ANNOUNCEMENTS
- WERFEN RECEIVES CE MARK FOR APTIVA ANTIPHOSPHOLIPID SYNDROME
- DIASORIN NABS FDA CLEARANCE FOR NEW LIAISON PLEX SYSTEM
- T2 BIOSYSTEMS OFFERS EXPANDED PANEL
- CEPHEID RECEIVED FDA CLEARANCE FOR XPERT XPRESS GBS
- DIACARTA COLLABORATION TO LAUNCH PROSTATE CANCER LDT
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook